Fig. 1From: Renal hemodynamic effects differ between antidiabetic combination strategies: randomized controlled clinical trial comparing empagliflozin/linagliptin with metformin/insulin glargineTreatment-induced percent change of renal and intraglomerular hemodynamicsBack to article page